Business
Full Year Results
Fevara PLC reported a strong turnaround for the year ended 31 August 2025, with revenue from continuing operations increasing by 4.1% to £78.8 million and adjusted operating profit rising by 69.2% to £3.7 million, driven by robust performance in the UK and Europe. The company also saw a significant improvement in its overall profit for the year, reaching £19.9 million compared to a loss of £5.7 million in the prior year, largely due to a £16.9 million profit from discontinued operations. Fevara's strategic transformation included the sale of its Engineering Division for £75 million and a £70 million return of cash to shareholders via a tender offer, alongside a proposed final dividend of 1.2 pence per share. Post-period, the company announced an agreement to acquire Macal in Brazil, signaling expansion into new growth markets. Disclaimer*
About this update from Fevara Plc
[{"type":"text","content":"\n\n \n10 December 2025\nFevara plc\n(\"Fevara\", the \"Company\" or the \"Group\")\n \nFull year results for the year ended 31 August 2025\n \nA year of turnaround, transformation and strong progress\n \n \nFevara plc (LSE: FVA), an international specialist in livestock supplements, is pleased to announce its results for the year ended 31 August 2025 (\"FY25\" or the \"Period\").\n \n \n\n\n\n\n \n\n\n FY25\n\n\n FY24\n\n\n Change \n\n\n\n\nContinuing operations\n\n\n\n\n\n\n\n\n\n\n\n\n\nRevenue\n\n\n£78.8m\n\n\n£75.7m\n\n\n+4.1%\n\n\n\n\nAdjusted operating profit\n\n\n£3.7m\n\n\n£2.2m\n\n\n+69.2%\n\n\n\n\nOperating profit/(loss)\n\n\n£2.4m\n\n\n£(6.8)m\n\n\n+135.1%\n\n\n\n\nAdjusted profit before tax\n\n\n£4.2m\n\n\n£2.5m\n\n\n+67.0%\n\n\n\n\nProfit/(loss) for the year\n\n\n£3.0m\n\n\n£(4.5)m\n\n\n+167.4%\n\n\n\n\nNet cash1\n\n\n£2.6m\n\n\n£8.0m\n\n\n-68.1%\n\n\n\n\nAdjusted earnings per share\n\n\n4.4p\n\n\n2.6p\n\n\n+69.2%\n\n\n\n\nGroup\n\n\n\n\n\n\n\n\n\n\n\n\n\nProfit/(loss) from discontinued operations2\n\n\n£16.9m\n\n\n(£1.2)m\n\n\n+1473.4%\n\n\n\n\nProfit/(loss) for the year\n\n\n£19.9m\n\n\n(£5.7)m\n\n\n+448.5%\n\n\n\n\nBasic EPS: Continuing\n\n\n3.5p\n\n\n(4.8)p\n\n\n+172.9%\n\n\n\n\nBasic EPS: Discontinued\n\n\n19.6p\n\n\n(1.3)p\n\n\n1607.7%\n\n\n\n\nFinal dividend per share\n\n\n1.2p\n\n\n2.85p\n\n\n-57.9%\n\n\n\n\nTotal dividend per share\n\n\n2.4p\n\n\n5.20p\n\n\n-53.8%\n\n\n\n\n 1excludes restricted cash (see pension disclosures)\n2includes profit on disposal in FY25\n \n \nFinancial highlights (continuing operations only)\n \n· Total revenue increased by 4.1% (5.7% at constant exchange rate) to £78.8m (FY24: £75.7m), reflecting a strong performance across our key markets, underpinned by the growing demand for performance-led, research-proven livestock supplements.\n \n· Group adjusted operating profit increased by 69.2% to £3.7m (FY24: £2.2m), and adjusted profit...